How are the institutional, ‘sophisticated’ and ‘professional’ investors that took part in this $1.50 per share capital raising feeling today?
$1.50 to 11 cents in 3.5 years.
And Starpharma have not managed to get even a single solitary new drug into the clinic despite this stellar capital raising. Now the new CEO has admitted the company is looking at going into capital preservation mode.
Is a 6 person board plus an advisor to the board really necessary for a micro cap company? Wouldn’t surprise me if CM was looking at reducing headcount across the company starting with minion staff members.
https://announcements.asx.com.au/asxpdf/20200930/pdf/44n4yy4wcyt0jd.pdf
How are the institutional, ‘sophisticated’ and ‘professional’...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $20.24K | 175.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 267920 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 192261 | 10 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
-0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.8¢ | 11.0¢ | 32412 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| SPL (ASX) Chart |